Overview
No overview information available.
Background
No background information available.
Indication
用于治疗脑血管疾病如脑供血不足、脑血栓、脑栓塞及脑出血恢复期;肝病、神经外科手术等引起的意识功能低下;智力减退、记忆力障碍等。还可用于治疗冠心病、脉管炎等。
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|
No clinical trials found
No clinical trials found for this drug
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| Safflower and Aceglutamide Injection | 国药准字H22026637 | 化学药品 | 注射剂 | 8/10/2020 | |
| Safflower and Aceglutamide Injection | 国药准字H22026638 | 化学药品 | 注射剂 | 8/10/2020 | |
| Safflower and Aceglutamide Injection | 国药准字H22026582 | 化学药品 | 注射剂 | 8/10/2020 |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||